Indication

Pituitary-dependent Cushing's disease

Pituitary-dependent Cushing's disease is an endocrine disorder classified as a form of endogenous ACTH-dependent hypercortisolism, primarily arising from a benign adrenocorticotropic hormone (ACTH)–secreting pituitary neuroendocrine tumor (corticotroph adenoma). Read more about Pituitary-dependent Cushing's disease

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Pituitary-dependent Cushing's disease therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Pituitary-dependent Cushing's disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pituitary-dependent Cushing's disease.

Pituitary-dependent Cushing's disease is an endocrine disorder classified as a form of endogenous ACTH-dependent hypercortisolism, primarily arising from a benign adrenocorticotropic hormone (ACTH)–secreting pituitary neuroendocrine tumor (corticotroph adenoma).

This sustained hypersecretion of ACTH drives bilateral adrenal cortical hyperplasia and unchecked systemic cortisol overproduction, disrupting the hypothalamic-pituitary-adrenal axis.

The condition impacts multiple body systems, predominantly affecting adults and leading to clinical hallmarks such as central obesity, facial plethora, purple abdominal striae, proximal muscle weakness, hypertension, and glucose intolerance.

Affected individuals also face substantial risks of long-term metabolic, cardiovascular, skeletal, and neuropsychiatric complications stemming from chronic hypercortisolemia.

Personalize your experience

Follow Pituitary-dependent Cushing's disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it